chrisvoncsefalvay/vaers-outcomes huggingface dataset:
lost the sense of smell and taste; Lost the sense of smell and taste; I have trouble breathing; Chills; Fever; body aches/pain; Sore throat; very weak; felt really bad/not feeling well; This is a spontaneous report from a contactable consumer (patient). This male patient of unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 17Apr2021 as single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not provided. On Saturday 17Apr2021, patient received the first dose of the COVID-19 vaccine from Pfizer. On Sunday (18Apr2021), he was not feeling well and felt really bad. On Monday (19Apr2021), he had chills, fever, body aches/pain, sore throat, he felt very bad, very weak. Today (21Apr2021), patient woke up feeling better, but about an hour ago he felt like he had lost the sense of smell and taste, and he had trouble breathing. On 21Apr2021, patient felt great, but now he had lunch and lost his sense of smell and taste. On Friday 16Apr2021 (1 day before receiving the vaccine), he got tested to see if he was infected with COVID-19 and it came back negative, 10 days ago he also had a test and it was negative, so he claimed that he did not have COVID and these symptoms should be because of the vaccine. Lab data included COVID-19 with result of negative on unspecified date and on 16Apr2021. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Severe headache lasting hours, sustained fever over 101F lasting 24 hours, nausea lasting 24 hours, malaise lasting 24 hours, sore arm lasting 3 days.
pfizer vaccine was mixed with sterile water instead of 9% normal saline.   dose give was 0.5ml instead of 0.3ml as well.
Got shingles on his back six days after the Pfizer vaccination. Probably not related to the vaccine but wanted to report just in case.
pt recvd vax;high fever of 104.7 shortly p/ immun;6:20pm airway closed;EMS called & pt to hosp;seen by MD; advise to give DT in future;
He also gets headaches in the morning around the same time; He has become a real dreamer and only sleeps three hours a night/ he has never been a dreamer and now has about 9 dreams a night; 12 hours after receiving the second dose of the vaccine it attacked his left knee and he couldn't walk/It attacked his right knee and ankle; 12 hours after receiving the second dose of the vaccine it attacked his left knee and he couldn't walk; This is a spontaneous report from a contactable consumer (patient) via medical information team. A 60-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) via unknown route of administration on 02Mar2021 at single dose for COVID-19 immunization. Medical history included stent being placed. Concomitant medications included acetylsalicylic acid (ASPIRIN 81) at 81 mg, daily. Patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) for COVID-19 immunization. Patient stated he has received both doses of the Pfizer COVID vaccine and he received the second dose on 02Mar2021. Patient states he has been healthy all his life minus a stent being placed. Patient stated 12 hours after receiving the second dose of the vaccine it attacked his left knee and he couldn't walk in Mar2021. Patient stated the next morning his left knee was fine but then it attacked his right knee and ankle in Mar2021. He also gets headaches in the morning around the same time on 03Mar2021. Patient stated he has become a real dreamer and only sleeps three hours a night. Patient states he has never been a dreamer and now has about 9 dreams a night in Mar2021. Patient states he was not able to take a lot of ibuprofen and he only takes an 81 mg aspirin daily. The outcome of events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Pt states Tdap given on 12/27/17, couple hours later felt tingling/numbness to (L) arm. Worsened one day later radiating to Bilateral arms and has now worsened to whole body. Pt sates onset of itch discomfort for the past week, chest palpitations for the past 3 days with no improvement. OTC AA, ADVIL, BENADRYL with no help. Symptoms progressed to fluctuating tingling of multiple parts of body, then in second week shooting pains, by third week fluctuating weakness and tingling.
Several leg cramps throughout both legs. Still having leg cramps in my right leg. Went to emergency room 4/29 with chest, arm and leg pains. Was admitted for work up and testing came back negative. My d-dimer results was 483 where borderline is 500.
Swelling in fingers, toes, feet and ankles. Severe pain in shoulders, both knees and both feet. Unable to get up or hold anything with my hands. Taking fish oil, turmeric and motrin. Still going through pain, and Swelling still exists.
7-16-2010 Received Varicella 7-14-10 without incident. Relates "itchy arm" reddened warm area approx 1 1/2" in diameter at site of Varicella injection. No other symptoms.
This case was reported by a lawyer and described the occurrence of hearing loss unilateral in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis. On 19th October 2020, the patient received Shingrix (unknown). On an unknown date, immediately after receiving Shingrix, the patient experienced hearing loss unilateral (serious criteria GSK medically significant) and tinnitus. On an unknown date, the outcome of the hearing loss unilateral and tinnitus were not recovered/not resolved. It was unknown if the reporter considered the hearing loss unilateral and tinnitus to be related to Shingrix. The patient received her first Shingrix vaccine on 19/10/2020. Shortly after the vaccination she noticed a constant hissing in her left ear. Date of injury 04/12/2020.She went to ENT and was assessed with hearing loss and tinnitus after an MRI was performed. She continues to suffer from the constant ringing in her left ear.
Child was accidentally administered an adult dose of Pfizer vaccine. This causes lots of stress for family and medical staff administering vaccine. 48 hour follow up, mom reports child is fine with no symptoms. We will be providing ongoing care.
I had pretty extreme abdominal pain with vomiting. They did a pelvic ultrasound at ER - complex ovarian cyst and fluid in Fallopian tube. Zofran for nausea and two weeks of Doxycycline. And they had me follow up with OB/GYN which I did yesterday. The vomiting has resolved. I still have abdominal pain - but it's not as severe as it was on the 3rd of July.
Mom called to report pt had onset of cold symptoms, immediately, post vax. Pt had fever, congestion and on Friday, 1/21/2000, spiked fever of 101.5F. That night, noted eruptions on skin which appeared to be insect bites. Eruptions over entire body on Saturday. Pt does not appear to be in discomfort.
The COVID vaccine was given at 2046. At approx. 2050 patient complained of tingling to her left leg and a headache. Her vitals were obtained at 2050. They are as follows; B/P 146/86, HR 111, Spo2 98 on RA. She denied any SOB, chest pain or discomfort, no difficulty swallowing. She was able to ambulate to the wheelchair without any issues. I called house supervisor at 2049. He came up to asses her and she was transported to the ED by 2 MA's and a nurse. She was transported via wheelchair on the monitor. She did not require supplemental O2
Information has been received from a health professional concerning a 22 year old female receptionist who "over the past two weeks" was vaccinate with a dose of pneumococcal 23v polysaccharide vaccine. Subsequently, the pt developed LA pain that went down to her fingers and numbness of all of her arm and fingers. Unspecified medical attention was sought. No product quality complaint was involved.  The reporter expressed a concern with the lot. It was also reported that 3 other pts were vaccinated with a dose of pneumococcal 23v polysaccharide vaccine and developed adverse reactions ranging from a localized red mark to the pts not being able to lift their arm. The records of testing prior to release of this lot have been checked by QA and found to be satisfactory. The lot complies with the standards of the Center for Biologics Evaluation and research and was released.  Additional information has been requested.
Right sided tingling, right sided weakness, flashes of light of the left eye, interrupted sleep, right pinky turned purple.
This case was reported by a healthcare professional and described the occurrence of decreased therapeutic response in a 42-year-old female subject who was vaccinated with GENERIX B, GlaxoSmithKline for prophylaxis. Previous and/or concurrent vaccination included ADACEL; Sanofi Pasteur MSD given on 29 August 2008. There were no concurrent medications. On 29 August 2008, 10 October 2008 and 14 January 2009 the subject received 1st dose, 2nd dose and 3rd dose of ENGERIX B (unknown, right deltoid, left deltoid and left deltoid, respectively). On 14 January 2009, the subject experienced drug dose administration interval too short. On 25 February 2009, 42 days after vaccination with  ENGERIX B, the subject experienced decreased therapeutic response. On 25 February 2009, hepatitis B surface antibody was low at 5.2. A product complaint was associated with this report. Reporter states that 5 out of 6 subjects who received dose one from the same lot, dose 2 from the same lot experienced this adverse event. The subjects received the dose on a 0, 1, and 4 month schedule. The reporter did not believe there were any physical problems with the vaccines, but was questioning the quality and content of the vaccines. This reporter felt strongly that there was something potentially wrong with one of these vaccine lots because so many subjects did not become seroprotected. This is something she has not seen and she gives these vaccinations on a routine basis. Reporter believes a quality assurance problem caused the adverse event. Please see A0778211A, A0778217A, A0778218A and A0778220A. Follow-up information was received on 14 May 2009 Quality Assurance. Per the Quality Statement: ENGERIX vaccine lot numbers AHBVB073AA, AHBVB584AA and AHBVB670AA met the requirements of Quality Assurance's specifications and the batches were suitable for vaccination purposes.
No  adverse symptoms day of injection.  However, the next morning when getting out of bed every joint including neck and spine very achy to buckling me over.  Moaning to the breakfast table  felt absolutely miserable couldn't keep my eyes open, exhausted, went back to bed about 11 am and slept til 6 pm  periodically wakin gup and turning over (hurting)  fell back to seep..  Got up to recline, refused dinner, layed under thick wool blanket  with chills (in Florida).  Returned to bed 11pm.    Second Post Injection day sumptomatic except for low back pain. and stiffness.
Large itchy rash and swelling on left arm near the site of injection, developed on the seventh day from the day of vaccination.
The pt was noted to be more sleepy then it was on day after shots. Approx 4/1/04. Parents noted pt would stare off into space shortly after waking in AM. Also happened while eating and diaper changes about 1x1 day. Cold symptoms reported at same time. No fever. No unusual baby movements or color changes. Pt would snap out of it with stimulation. Exam 4/8/04 normal. Occurred daily from 4/1/04-4/9/04 and never since. This pt's mom notes developed slower than brother but still reached milestones at appropriate ages.
She can't coordinating in her mind; In bed for 25 or 21 days; Flusing in head/head fluttering; varicose veins in both legs; Medication spasms; Over fatigued; fever; developed chills; sever kidneys infection; urine was with blood; ringing in her ears; body aches; felt dizziness; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of KIDNEY INFECTION (sever kidneys infection) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced KIDNEY INFECTION (sever kidneys infection) (seriousness criterion medically significant), HAEMATURIA (urine was with blood), TINNITUS (ringing in her ears), PAIN (body aches), DIZZINESS (felt dizziness), CHILLS (developed chills) and PYREXIA (fever). On an unknown date, the patient experienced COGNITIVE DISORDER (She can't coordinating in her mind), BED REST (In bed for 25 or 21 days), HEAD DISCOMFORT (Flusing in head/head fluttering), VARICOSE VEIN (varicose veins in both legs), MUSCLE SPASMS (Medication spasms) and FATIGUE (Over fatigued). At the time of the report, KIDNEY INFECTION (sever kidneys infection), HAEMATURIA (urine was with blood), TINNITUS (ringing in her ears), PAIN (body aches), COGNITIVE DISORDER (She can't coordinating in her mind), BED REST (In bed for 25 or 21 days), HEAD DISCOMFORT (Flusing in head/head fluttering), VARICOSE VEIN (varicose veins in both legs), MUSCLE SPASMS (Medication spasms), CHILLS (developed chills), FATIGUE (Over fatigued) and PYREXIA (fever) outcome was unknown and DIZZINESS (felt dizziness) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-Mar-2021, SARS-CoV-2 antibody test: negative Negative. On an unknown date, Computerised tomogram: normal (normal) The kidneys are normal about 60 days after injection..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment was reported as antibiotics. relevant concomitant medications are piroanoctum, vitamin C & D, .   This case was linked to MOD-2021-057443 (Patient Link).; Sender's Comments: Limited information regarding the events has been provided at this time and a causal relationship cannot be excluded
Drug ineffective; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the patient.  A 74-year-old male patient received BNT162b2 (BNT162B2), on 04Oct2021 as dose 3 (booster), single (Lot number: ZW0167) at the age of 74 years, in left arm for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), on 08Apr2022 as dose 4 (booster), single (Lot number: 048L21A), in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), outcome "unknown"; COVID-19 (medically significant), outcome "unknown". Therapeutic measures were taken as a result of drug ineffective, covid-19. Anti-viral details: Product=COVID 19. Treatment. Brand=Pfizer. Treatment start date=21Apr2022. Treatment Stop date=26Apr2022.Indication=Treatment of COVID-19. Covid vaccine details: Vaccine brand=Other, Vaccine brand other=Moderna. Vaccine administration date=08Apr2022, Vaccine lot number= 048L21A, Vaccine dose number=4, Vaccine dose number unknown=False, Vaccine location=Left arm Vaccine brand=Pfizer / BioNTech, Vaccine brand unknown=False, Vaccine administration date=04Oct2021, Vaccine lot number= ZW0167, Vaccine lot unknown=False, Vaccine dose number=3, Vaccine dose number unknown=False, Vaccine location=Left arm. Adverse event: Relapse after Paxlovid. Adverse event country: (specified). Adverse events start date: 03May2022.AE resulted in: None of the above. If patient recovered: Recovering. If treatment ae: Yes. AE treatment: Paxlovid. Known allergies: No.; Sender's Comments: Based on the information in the case report, a possible causal relationship between reported events and suspect drug BNT162B2 cannot be excluded
Headache, Myalgia, NauseaVomiting, Fatigue Narrative: Unable to work full day, stayed home next day
INSOMNIA; NECK PAIN; HEADACHE; COULD NOT USE ARM; ARM WEAKNESS; PINCHED NERVE; FROZEN SHOULDER; THROBBING AND PULSATING PAIN IN RIGHT ARM; This spontaneous report received from a patient concerned a 61 year old female. The patient's height, and weight were not reported. The patient's past medical history included: mastectomy, radiation, and surgery, and concurrent conditions included: diabetes, high blood pressure, high cholesterol, high blood sugar, non-smoker, non-alcohol user, lymphedema in left arm, breast cancer, sciatic nerve pain, lumbar disease five discs in back deteriorated, and chemotherapy, and other pre-existing medical conditions included: The patient had no history of illicit drug use/abuse. The patient was also prescribed a muscle relaxer and takes at night and also used a massager for relief. The patient experienced drug allergy when treated with amitriptyline, and atorvastatin. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1821286, expiry: UNKNOWN) dose was not reported, administered on 30-JUN-2021 for prophylactic vaccination. Concomitant medications included anastrozole for breast cancer, insulin for diabetes, linagliptin for diabetes, diclofenac for left arm burning sensation, gabapentin, paracetamol, and pravastatin. On 01-JUL-2021, the patient experienced throbbing and pulsating pain in right arm. On 05-JUL-2021, the patient experienced pinched nerve. On 05-JUL-2021, the patient experienced frozen shoulder. On 05-JUL-2021, the patient experienced arm weakness. On 10-JUL-2021, the patient experienced could not use arm. On an unspecified date, the patient experienced insomnia, neck pain, and headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from headache, had not recovered from pinched nerve, frozen shoulder, insomnia, throbbing and pulsating pain in right arm, arm weakness, and neck pain, and the outcome of could not use arm was not reported. This report was non-serious.
Pfizer 3/3/21, 3/24/21, 12/3/21. Positive on 2/1/23.
Large axillary lymhnodes, both left and right sides. Still large 10 months later
Indicates autoimmune disease; This is a spontaneous report based on information received by Pfizer from Merck  service centre [01983572]. A contactable female consumer (patient) reported a female patient of an unspecified age received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13), via an unspecified route of administration on an unspecified date as single dose for immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced indicates autoimmune disease on an unspecified date. The consumer inquiring if the vaccine is a live vaccine as she reported it has just been " discovered" she has an autoimmune disease (unspecified). "it is not epstein-barr, but something is decreased which indicates autoimmune disease". The customer reported she received the Prevnar 13 vaccine a year ago (unspecified date) and after the vaccine, her symptoms started. The outcome of the event was unknown.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected.
REPOERTED BY FAMILY MEMBER THAT THEY FOUND PATIENT DEAD IN SLEEP, NOT BREATHING SUSPECTING HEART ATTACK...AUTOPSY WILL BE PERFORMED
104.5 degree fever, rigors, hallucinations, severe joint pain, headache, muscle weakness
ACUTE DVT OF RIGHT LEG, UNSPECIFIED VEIN ACUTE DVT OF LEFT LEG, UNSPECIFIED VEIN ACUTE DVT OF BILAT LEGS, UNSPECIFIED VEINS ACUTE DVT, UNSPECIFIED VEIN
Day 8 post vaccine, large area of erythema noted on left arm, 6.5cmx6.5cm. Site slightly itchy, raised, red, warm to touch.  Later that day pain up the left neck and left scapula area (similar to original injection site discomfort), myalgias, slight chills.  Increased in size on 1/9 to 8cmx6.5cm.  Redness and discomfort resolved 1/12, continues to be slightly itchy at the site at this time, usually at evening and night time.  Started Keflex for assumed cellulitis on 1/7/21, Keflex 500mg every 6 hours for 7 days.
since date of vaccination 5/29/2021, he started sneezing constantly, along with congestion and runny nose, tiredness,  OTC allergy and cold meds tried and failed.  Progressively got worse, ended up with sinus infection, one sinus swollen shut, rx'd Prednisone and abx yesterday (6/10/2021).  I don't know if its related but, he's never gotten sick like this or had a sinue infection before.  He is home for school (online) and only goes to soccer training in the evening.  No other reported illness on team at this time.
Three weeks after second Pfizer vaccine red spot appeared on right breast. then awoke with right breast triple the size and purple. Mass the size of three golf balls laterally. week and a half later mass moved longitudinal. Biopsies showed HERS2 three plus positive Genotype. Also had nerve pain running  down right armpit/lymph area to elbow. Also, had sharp nerve pain shooting across chest and severe diarrhea with undigested food. 18 weeks of high dose chemotherapy. To be followed by bilateral mastectomy with radical on the right. Will then rebiopsy and immunotherapy for another year. Left breast also developed mass 2nd to last round of chemo. Pending MRI on left breast.  Had my yearly mammogram and ultrasound two months prior and was cleared before the above. Have developed neuropathy in hands and feet from chemotherapy.
Ten minutes after receiving the vaccine she experienced throat tightness and numbness and tingling of her extremities. She was seen in the ED and given oral pepcid and benadryl with relief of symptoms within an hour.
I experienced severe nausea, fever, chills/ sweats, back, shoulders, legs aches, swelling, redness and soreness at injection sight. The nausea was the worse side affect. This lasted about 12 hours. I took ZOFRAN and TYLENOL and slept most of the day and night. The next day I felt fine although the site is still swollen, red and tender.
Information has been received from a physician concerning a female who was vaccinated with Gardasil. Subsequently the patient experienced syncope. Unspecified medical attention was sought. At the time of the report the patient recovered. Additional information has been requested.
Pt recv vax on 10/9/97; on 10/11/97 pt exp red rash over body
A non-serious spontaneous report of inadvertent administration of expired H1N1 was received  from a registered nurse/health professional concerning a six-year-old male. Neither relevant medical history nor concomitant medications have been reported for this patient. The original expiration date was 08-Apr-2010, which was reassigned to 29-Mar-2010. On 31-Mar-2010, the patient received the second dose of H1N1 vaccine, intranasal for an unknown indication. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments were not applicable and the event was considered to be resolved.
Changes in behavior and alertness, lethargic.  Brain swelled, screaming if anything touched the head/skull. Severe symptoms lasted for 2 days.  Lymph nodes erupted across the entire back of the head and neck and remained large for months.